The pan-deacetylase inhibitor panobinostat induces cell death and synergizes with everolimus in Hodgkin lymphoma cell lines
出版年份 2012 全文链接
标题
The pan-deacetylase inhibitor panobinostat induces cell death and synergizes with everolimus in Hodgkin lymphoma cell lines
作者
关键词
-
出版物
BLOOD
Volume 119, Issue 17, Pages 4017-4025
出版商
American Society of Hematology
发表日期
2012-03-11
DOI
10.1182/blood-2011-01-331421
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cytotoxic activity of the histone deacetylase inhibitor panobinostat (LBH589) in anaplastic thyroid cancer in vitro and in vivo
- (2011) Maria Graziella Catalano et al. INTERNATIONAL JOURNAL OF CANCER
- Targeting Glucose Metabolism
- (2010) Brijesh M. Madhok et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- The pan-DAC inhibitor LBH589 is a multi-functional agent in breast cancer cells: cytotoxic drug and inducer of sodium-iodide symporter (NIS)
- (2010) N. Fortunati et al. BREAST CANCER RESEARCH AND TREATMENT
- The class-I HDAC inhibitor MGCD0103 induces apoptosis in Hodgkin lymphoma cell lines and synergizes with proteasome inhibitors by an HDAC6-independent mechanism
- (2010) Daniela Buglio et al. BRITISH JOURNAL OF HAEMATOLOGY
- Exploring mammalian target of rapamycin (mTOR) inhibition for treatment of mantle cell lymphoma and other hematologic malignancies
- (2010) Bertrand Coiffier et al. LEUKEMIA & LYMPHOMA
- Inhibition of histone deacetylase overcomes rapamycin-mediated resistance in diffuse large B-cell lymphoma by inhibiting Akt signaling through mTORC2
- (2009) M. Gupta et al. BLOOD
- Preliminary evidence of disease response to the pan deacetylase inhibitor panobinostat (LBH589) in refractory Hodgkin Lymphoma
- (2009) Michael Dickinson et al. BRITISH JOURNAL OF HAEMATOLOGY
- Clinical Studies of Histone Deacetylase Inhibitors
- (2009) H. M. Prince et al. CLINICAL CANCER RESEARCH
- Histone deacetylase inhibitors: Potential in cancer therapy
- (2009) P.A. Marks et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Histone Deacetylase Inhibitors in Cancer Therapy
- (2009) Andrew A. Lane et al. JOURNAL OF CLINICAL ONCOLOGY
- Vorinostat inhibits STAT6-mediated TH2 cytokine and TARC production and induces cell death in Hodgkin lymphoma cell lines
- (2008) D. Buglio et al. BLOOD
- Targeting tumor angiogenesis with histone deacetylase inhibitors
- (2008) Leigh Ellis et al. CANCER LETTERS
- Role of mTOR in anticancer drug resistance: Perspectives for improved drug treatment
- (2008) Bing-Hua Jiang et al. DRUG RESISTANCE UPDATES
- Glucose Metabolism as a Target of Histone Deacetylase Inhibitors
- (2008) Suzanne E. Wardell et al. MOLECULAR ENDOCRINOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation